SAN DIEGO, Oct. 18, 2016 /PRNewswire/ -- ResMed (NYSE: RMD),
the global leader in medical devices and digital connected care for
the diagnosis, treatment and management of sleep apnea, is teaming
up with "The Dr. Oz Show" to launch a campaign to foster better
public understanding of sleep health.
The campaign will kick off on "The Dr. Oz Show" airing
Thursday, October 20.
Dr. Oz Show viewers will have the opportunity to enroll in a
national sleep survey and be eligible to receive a free S+ by
ResMed. ResMed will be giving away 1,000 of its award-winning S+
sleep monitors. S+ by ResMed is the world's first non-contact sleep
tracker and smartphone app designed to help people track, better
understand and improve their sleep.
ResMed and "The Dr. Oz Show" will use sleep data anonymously
collected from the show's registered S+ users to determine, for the
first time, America's overall "Sleep Score."
To demonstrate how the S+ by ResMed determines sleep scores,
several Dr. Oz Show viewers have been provided with the S+ and
asked to log their sleep scores, which will range between zero and
100.
Dr. Michael Breus, a clinical
psychologist, Diplomate of the American Board of Sleep Medicine,
Fellow of The American Academy of Sleep Medicine, and member of
"The Dr. Oz Show's" clinical advisory board, will reveal the sleep
scores of each of these viewers on the October 20 broadcast.
"Sleep is the most underappreciated health crisis in America,"
said Dr. Mehmet Oz, host of "The Dr.
Oz Show." "Type 'Why am I' into Google and the first and
most commonly searched terms are 'so tired' and 'always
tired.' In our surveys, 42 percent of respondents sleep less than
six hours a night. This partnership with ResMed is a great way for
us to assess the sleep habits of our nation. Understanding public
health patterns lets us build new pathways to wellness, and sleep
is an area where we can make a huge difference."
"We are excited about highlighting the importance of healthy
sleep with Dr. Oz, and promoting the need for a sleep revolution,"
said Colin Lawlor, ResMed's vice
president of consumer programs. "Our goal is to give Dr. Oz's
viewers and the general public a greater appreciation for sleep by
empowering them with the technology that can help them lead more
productive, healthier and happier lives."
As part of the campaign, more than 20,000 viewers will also be
able to participate and purchase an S+ by ResMed for only
$50 (a $79.99 discount from the manufacturer's suggested
retail price), by redeeming a code through www.doctoroz.com.
For more information about the campaign, including terms and
conditions, visit www.sleepscore.com. Dr. Oz has partnered with
ResMed, maker of the S+ device, to promote sleep awareness and
healthy sleep.
Viewers that enroll in the survey will also be entered to win a
romantic dream vacation to the newest property in the portfolio of
Six Senses Hotels Resorts Spas: Six Senses Zil Pasyon. The resort
is located on the private island of Félicité in the Seychelles, accessible by helicopter or
speedboat, and features 30 pool villas.
About S+
S+ by ResMed is the world's first non-contact sleep tracker,
which uses patented bio-motion sensors to measure your sleep stages
and environment, and deliver personalized feedback that helps
improve your sleep from the very first night. It monitors breathing
patterns and body movements without requiring uncomfortable
wristbands, mattress strips or electrodes. It also captures the
light, noise and temperature levels in your room, and lets you log
lifestyle factors that can affect sleep such as caffeine and
exercise, to analyze patterns over time and deliver personalized
sleep strategies.
The capabilities of the S+ go beyond those of fitness devices
available on the market. Its personalized suggestions are informed
by more than two million nights of sleep data. It offers the most
accurate sleep score available in any home-based technology. Its
accuracy is validated in more than 10 clinical studies. The S+ has
also won awards from Frost & Sullivan, Red Dot and CES. Learn
more at mySplus.com.
About ResMed
ResMed (NYSE:RMD) changes lives with award-winning medical
devices and cutting-edge cloud-based software applications that
better diagnose, treat and manage sleep apnea, chronic obstructive
pulmonary disease (COPD) and other chronic diseases. ResMed is a
global leader in connected care, with more than 2 million patients
remotely monitored every day. Our 5,000-strong team is
committed to creating the world's best tech-driven medical device
company – improving quality of life, reducing the impact of chronic
disease, and saving healthcare costs in more than 100
countries.
ResMed.com | Facebook | Twitter | LinkedIn
ResMed
Contacts:
|
|
For News
Media
|
For
Investors
|
Alison
Graves
|
Agnes Lee
|
Director, Corporate
Communications
|
Senior Director,
Investor Relations
|
O: +1
858-836-6789
|
O: +1
858-836-5971
|
news@resmed.com
|
investorrelations@resmed.com
|
|
|
|
|
Logo -
http://photos.prnewswire.com/prnh/20140310/LA79234LOGO-a
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/national-sleep-survey-launch-on-the-dr-oz-show-to-determine-americas-sleep-score-300346469.html
SOURCE ResMed Inc.